These Food and Drug Administration (FDA) developments recently came in:

Recall: Telmisartan Tablets

Alembic Pharmaceuticals Inc. is voluntarily recalling 1 lot of telmisartan tablets, 20 mg, packaged in 30-count bottles. The product is being recalled due to a market complaint received which stated that 1 bottle labelled as 20 mg telmisartan tablets incorrectly contained 40 mg telmisartan tablets. Telmisartan is used for the treatment of hypertension. Patients who could be on a doubled dose of telmisartan for a prolonged period of time could experience low blood pressure, worsening of kidney function, or an elevation of potassium which can be life-threatening. To date, Alembic Pharmaceuticals has not received any reports of adverse events related to this recall. More Information.

Benzedrex (propylhexedrine): Drug Safety Communication

The FDA is warning that the abuse and misuse of the over-the-counter (OTC) nasal decongestant propylhexedrine can lead to serious harm such as heart and mental health problems. Some of these complications, which include fast or abnormal heart rhythm, high blood pressure, and paranoia, can lead to hospitalization, disability, or death. Reports of individuals abusing and misusing propylhexedrine have increased in recent years. Propylhexedrine is safe and effective when used as directed. More Information.